Workflow
Consolidated Water Sets Third Quarter 2025 Investor Conference Call for Tuesday, November 11, 2025 at 11:00 a.m. ET
Globenewswire· 2025-11-03 21:31
GEORGE TOWN, Cayman Islands, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading designer, builder and operator of advanced water supply and treatment plants, will hold a conference call on Tuesday, November 11, 2025 at 11:00 a.m. Eastern time to discuss its results for the third quarter ended September 30, 2025.The financial results will be issued in a press release prior to the call. Consolidated Water management will host the call, followed by a qu ...
RESEARCH FRONTIERS TO HOST THIRD QUARTER 2025 CONFERENCE CALL
Globenewswire· 2025-11-03 21:30
WOODBURY, NY, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced today that it will release its third quarter 2025 financial results on Thursday, November 6, 2025. Research Frontiers will also host a conference call at 4:30 p.m. Eastern Time on Thursday, November 6, 2025 to discuss its third quarter 2025 financial and operating results, as well as recent developments. Who: Joseph M. Harary, President & CEODate/Time: Thursday, November 6, 2025, 4:30 PM ETDial-in Information: 1 ...
ZOOZ Strategy Announces a $50 Million Share Repurchase Program, Subject to Meeting Regulatory Requirements
Globenewswire· 2025-11-03 21:30
TEL AVIV, Israel, Nov. 03, 2025 (GLOBE NEWSWIRE) -- ZOOZ Strategy Ltd. (Nasdaq & TASE: ZOOZ) (the “Company”) announced today that its Board of Directors has approved the adoption of a share repurchase program to acquire up to $50 million of the Company’s outstanding ordinary shares, subject to meeting applicable regulatory requirements. The share repurchase program is for a 12-month period and will allow the Company to repurchase its shares from time to time using a variety of methods, including open market ...
LiveOne (Nasdaq: LVO) Accelerates Revenue Growth with Intuizi AI, Driving Tesla Subscriber Conversions
Globenewswire· 2025-11-03 21:30
合作公告概述 - LiveOne旗下全资子公司Slacker与AI客户获取平台Intuizi建立合作伙伴关系 [2] - 合作利用Intuizi的大型定量模型,通过AI驱动的营销智能加速Slacker Plus和Premium订阅层的采用 [2] - Intuizi的LQM模型基于数万亿去标识化消费者信号训练,能在最佳时机识别并吸引潜在订阅用户,特别是在汽车领域 [2] 业务表现与战略规划 - 在汽车垂直领域已观察到强劲的增长势头,验证了AI提升营销绩效的能力 [3] - 基于此成功,公司计划将项目扩展至零售、运营商、社交媒体平台、流媒体服务和酒店等其他行业 [3] - 特斯拉广告支持订阅用户数在过去一年内增长至超过100万 [5] - 每用户平均收入增长60%至超过5美元 [5] - 自合作启动以来,订阅参与度提升31%以上,Plus/Premium套餐转化率提升22%以上 [5] 公司背景 - LiveOne是一家获奖的、以创作者为先的音乐、娱乐和技术平台,专注于在全球提供优质体验、原创内容以及现场和虚拟活动 [3] - 公司总部位于加利福尼亚州洛杉矶,旗下拥有多家子公司 [3]
BTCS to Participate in Upcoming November Conferences
Globenewswire· 2025-11-03 21:30
WAYNE, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a blockchain technology-focused company, short for Blockchain Technology Consensus Solutions, today announced that management will be participating in the following November 2025 investor conferences. Blockchain FuturistDates: November 5-6, 2025Location: DAER + The Hard Rock Guitar Hotel & Casino, Miami, FL Cantor Crypto ConferenceDates: November 10-12, 2025Location: The Ritz-Carlton South Beach, Miami, FL The ...
InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation
Globenewswire· 2025-11-03 21:30
Agreements formalize research partnership combining InterCure’s global pharmaceutical platform with Cannasoul’s world-class analytics and scientific innovation Collaboration comes amidst reports that the Trump administration is exploring cannabis rescheduling, expected to create unprecedented opportunities in the U.S. for international operators like InterCure NEW YORK & HERZLIYA, Israel , Nov. 03, 2025 (GLOBE NEWSWIRE) -- InterCure Ltd. (Nasdaq: INCR / TASE: INCR) (“InterCure” or the “Company”) today annou ...
Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation
Globenewswire· 2025-11-03 21:30
监管审评进展 - 公司已向美国FDA提交了cytisinicline新药申请审评所需的120天安全更新数据[1][7] - FDA已接受该新药申请并指定PDUFA目标日期为2026年6月20日[5] - 数据安全监测委员会完成对ORCA-OL长期安全性试验的第四次也是最后一次审查 未发现任何药物安全问题[1][7] 临床试验成果 - ORCA-OL长期安全性试验成功完成 共有334名参与者完成了为期一年的累积治疗 显著超过FDA要求的100名参与者标准[3][7] - 该试验旨在满足FDA对NDA审评的要求 即至少300名参与者提供6个月累积安全数据 至少100名参与者提供一年数据[4][7] - 截至2025年6月4日的数据截止点 安全更新数据包含411名至少有6个月累积cytisinicline暴露的参与者和214名至少有一年暴露的参与者[7] 产品与市场潜力 - Cytisinicline是一种植物基生物碱 具有高尼古丁乙酰胆碱受体结合亲和力 通过减少尼古丁渴求症状和产品满足感来帮助治疗尼古丁成瘾[9] - 美国约有2900万成年吸烟者和1700万成年电子烟使用者 2024年约有160万中学生报告使用电子烟[6][8] - 目前尚无FDA批准的专门用于辅助尼古丁电子烟戒断的治疗方法 该产品有望成为近二十年来首个获FDA批准的戒烟新疗法[2][8]
Amarin To Present New Analyses Affirming Robustness of Data from REDUCE-IT and Additional Mechanisms of Action of Eicosapentaenoic Acid (EPA) at American Heart Association (AHA) Scientific Sessions 2025
Globenewswire· 2025-11-03 21:30
DUBLIN and BRIDGEWATER, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, today announced it will be presenting new findings at the American Heart Association's Scientific Sessions 2025 scheduled for November 7-10 in New Orleans, Louisiana. These new data supported by Amarin will further reinforce the robust efficacy of VASCEPA®/VAZKEPA® (icosapent ethyl) in cardiovascular risk reduction (CVRR) as well as highl ...
PureCycle Announces Appointment of a New Member to the Board of Directors
Globenewswire· 2025-11-03 21:30
Dr. Siri Jirapongphan Joins PureCycle Board; Jeffrey R. Fieler Resigns as DirectorORLANDO, Fla., Nov. 03, 2025 (GLOBE NEWSWIRE) -- PureCycle Technologies, Inc. (Nasdaq: PCT), a U.S.-based company revolutionizing plastic recycling, announced today the appointment of Dr. Siri Jirapongphan to its board of directors, effective October 28, 2025. Dr. Jirapongphan currently serves as an independent director and Chairman of the Audit Committee of Bangkok Bank PLC. Additionally, he has served as Director and Treasur ...
IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Results
Globenewswire· 2025-11-03 21:30
Announces Regular Quarterly Cash Dividend of $0.17 Per Share and Raises Full-Year GuidanceReports record revenue of $21.2 million for the third quarter of 2025, an increase of $2.9 million, or 16%, compared to the same period in 2024.Reports record GAAP diluted EPS of $0.43 and non-GAAP diluted EPS of $0.47 for the third quarter of 2025, which are increases of 8% and 9%, respectively, compared to the same period in 2024.Raises full-year guidance to revenue of $82.5 million to $83.5 million and GAAP diluted ...